Section Arrow
IPSC.NASDAQ
- Century Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2025/09/03 18:55 EDT
After Hours
Last
 0.4775
+0.0093 (+1.99%)
Bid
0.47
Ask
0.48
High 0.48 
Low 0.4665 
Volume 1675 
Regular Hours
Last
 0.4682
-0.0076 (-1.60%)
Day High 
0.4957 
Prev. Close
0.4758 
1-M High
0.5875 
Volume 
396.38K 
Bid
0.47
Ask
0.48
Day Low
0.466 
Open
0.47 
1-M Low
0.4601 
Market Cap 
41.10M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.52 
20-SMA 0.53 
50-SMA 0.56 
52-W High 1.8599 
52-W Low 0.3418 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.28/-1.56
Enterprise Value
90.06M
Balance Sheet
Book Value Per Share
2.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.59M
Operating Revenue Per Share
0.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
After Hours 0.4169 -0.0405 -8.85%
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
After Hours 0.0536 +0.001 +1.90%
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
After Hours 0.3515 -0.0184 -4.97%
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
After Hours 2.5 -0.02 -0.79%
STTKShattuck Labs1.28+0.27+26.73%-- 
After Hours 1.27 -0.01 -0.78%
Quotes are at least 15-min delayed:2025/09/03 18:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.